Skip to content

UVC in Prevention of Surgical Wound Infection

UVC in Prevention of Surgical Wound Infection

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07600463
Acronym
UVCJAS
Enrollment
75
Registered
2026-05-20
Start date
2026-06-04
Completion date
2029-12-31
Last updated
2026-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrocephalus

Keywords

Surgical infection, Prevention, UVC

Brief summary

The LF-PODD study investigates the use of UVC (270nm) light in the prevention of surgical wound infections. Three devices are used in the study, two of which are actively producing UVC light (265 and 275 nm) and one device does not produce UVC light at all. The devices are outwardly completely identical and the devices are drawn for the research participants. Volunteers for neurosurgical procedures are selected for the study. Everyone participating in the study will be informed about the research and written consent will be requested. In the study, UVC light is focused on the surgical area at the beginning of the neurosurgical operation, during the operation, the device automatically dispenses UVC light into the air of the surgical area every 20 minutes, and at the end of the surgical procedure, the device delivers a single dose of UVC light to the surgical wound after closing the surgical wound. Study participants are monitored according to the standard treatment protocol and, in particular, the inflammation of the surgical wound is monitored. The results of the study are recorded and analysed using statistical methods.

Detailed description

The following are recruited for the study: 75 patients undergoing elective CSF shunt surgeries

Interventions

UVC irradiation of surgical area

Sponsors

Ville Leinonen
Lead SponsorOTHER
Led Future Oy
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Randomization 1:1:1 into active UVC 265 nm, active UVC 275 nm and sham.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* 75 patients with idiopathic normal pressure hydrocephalus (iNPH) arriving for CSF shunt procedure * written informed consent

Exclusion criteria

* immunosupressive medication * pregnancy * medication sensitizing for light exposure (e.g. doxycycline)

Design outcomes

Primary

MeasureTime frameDescription
The antimicrobial effects of UVC light in the edges of the surgical wound and nucleic acid detections*immediately after surgeryThe ability of UVC light to reduce the incidence of LHI pathogens in surgical wounds: The antimicrobial effects of UVC light are investigated from smear samples taken from the edges of the surgical wound and nucleic acid detections, from which live and dead microbes can be determined.

Secondary

MeasureTime frameDescription
Safety of UVC radiationimmediately after surgeryPotential harm and benefits to surgical wound tissues: The potentially dangerous effects of healthy tissue at the cellular level are investigated from skin and subcutaneous tissue samples from the wound edge 2 mm x 1 cm.

Countries

Finland

Contacts

CONTACTVille Leinonen, Professor
ville.leinonen@kuh.fi+358447172303
CONTACTPaula Walle, MD PhD
paula.walle@kuh.fi+358447176321

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026